VIMAC Milestone Medical Fund
4
8M
4
2
- Stages of investment
- Areas of investment
Summary
Among the most successful fund investment fields, there are Health Care, Manufacturing. The fund has specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Rapid Micro Biosystems, Mimetogen Pharmaceuticals, AngioChem Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The high activity for fund was in 2005. Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the VIMAC Milestone Medical Fund, startups are often financed by iNovia Capital, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are TVM Capital, Quaker BioVentures, MSBi Valorisation. In the next rounds fund is usually obtained by Medwell Capital, TVM Capital, TPG Biotech.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 2
- Investments by industry
- Biotechnology (4)
- Pharmaceutical (3)
- Health Care (2)
- Manufacturing (1)
- Health Diagnostics (1) Show 2 more
- Investments by region
-
- United States (2)
- Canada (2)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Neotropix | 02 Feb 2005 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 10M | United States, Pennsylvania, Malvern |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.